Toward precision oncology: SERS microfluidic systems for multiplex biomarker analysis in liquid biopsy

Liquid biopsy-based diagnosis in precision oncology exhibits significant advantages over the traditional tissue biopsies by offering dynamic assessment of tumour heterogeneity, minimally invasive procedures for frequent sampling, and cost-effective tests.